SUPPLEMENTARY INFORMATION

Size: px
Start display at page:

Download "SUPPLEMENTARY INFORMATION"

Transcription

1 doi: /nature15260 Supplementary Data 1: Gene expression in individual basal/stem, luminal, and luminal progenitor cells. Box plots show expression levels for each gene from the 49-gene differentiation signature in individual cells. P-values and fold change for each gene are shown in Supplementary Table 2. Black dots, single cells; red dots, single cells with no expression. B, basal; LP, luminal progenitor; L, luminal. Supplementary Data 2: Full heatmaps showing unsupervised hierarchical clustering 1

2 2 HCI-001 KIT NOTCH3 GATA3 CD10 NOTCH4 SNAI2 CDK1 BCL2 TGFB2 AR CAV1 BCL2L1 SKP2 LGR5 CCNE1 KRT5 TP63 COL1A2 JAG1 ERBB3 KRT19 ITGB1 CD24 CLDN4 CAV2 EMP1 CDH3 CDH1 PARP2 CCNB1 PROM1 ERBB2 MYCN ESR2 MUC1 PTEN ITGA6 MYLK PGR PLCB4 TP53 Basal/stemlike ( Low enriched) Luminal-like ( High enriched) Intermediate

3 3 SUPPLEMENTARY INFORMATION HCI-002 KIT CCNB1 MUC1 EMP1 CD24 CAV2 ITGB1 CDH1 GATA3 KRT19 PTEN PROM1 CDK1 TP63 ERBB2 PARP2 ERBB3 CLDN4 ERBB1 TP53 CCNE1 MYLK ITGA6 CDH3 COL1A2 NOTCH3 JAG1 PLCB4 ESR2 KRT5 SNAI2 CAV1 AR BCL2L1 SKP2 NOTCH4 BCL2 LGR5 TGFB2 PGR MYCN CD10 Basal/stem-like ( Low enriched) Luminal-like ( High enriched)

4 4 HCI-010 KIT CCNB1 MUC1 EMP1 CD24 CAV2 ITGB1 CDH1 GATA3 KRT19 PTEN PROM1 CDK1 TP63 ERBB2 PARP2 ERBB3 CLDN4 ERBB1 TP53 CCNE1 MYLK ITGA6 CDH3 COL1A2 NOTCH3 JAG1 PLCB4 ESR2 KRT5 SNAI2 CAV1 AR BCL2L1 SKP2 NOTCH4 BCL2 LGR5 TGFB2 PGR MYCN CD10 Basal/stem-like ( Low enriched) Luminal-like ( High enriched) Intermediate

5 HCI #453 (Resected animal) Red = 10.4% Red = 4.2% Luminal-like mets, post-resection (red) = 85.4% Basal/stem-like ( Low enriched) Intermediate Luminal-like ( High enriched) KIT CCNB1 MUC1 EMP1 CD24 CAV2 ITGB1 CDH1 GATA3 KRT19 PTEN PROM1 CDK1 TP63 ERBB2 PARP2 ERBB3 CLDN4 ERBB1 TP53 CCNE1 MYLK ITGA6 CDH3 COL1A2 NOTCH3 JAG1 PLCB4 ESR2 KRT5 SNAI2 CAV1 AR BCL2L1 SKP2 NOTCH4 BCL2 LGR5 TGFB2 PGR MYCN CD10 Clustering by PDX model PDX model HCI-001 HCI-002 HCI-010 CLDN7 CD24 CD44 PARP2 BRCA1 PTEN CD10 THY1 TGFB2 Supplementary Data 2: Full heatmaps showing unsupervised hierarchical clustering analyses shown in Extended Data Fig. 4 Supplementary Data 3: Gene expression in individual lung metastatic cells from each of the 5

6 SUPPLEMENTARY INFORMATION Supplementary Data 3: Gene expression in individual lung metastatic cells from each of the three PDX models (HCI-001, HCI-002, and HCI-010). Box plots show expression levels for each of the 53 genes differentially expressed between the models by Anova. Black dots, single cells; red dots, single cells with no expression. 6

7 DNA damage response and repair Chromatin modification and gene regulation Development and differentiation *NS *NS *NS Cell cycle Other Supplementary Data 4: Gene ontology (GO) enrichment analysis reveals several biological processes are differentially regulated in low-burden metastatic cells. GO enrichment analysis was performed to identify pathways that were more represented in the set of significantly differentially expressed genes than would be expected by chance alone. Pathways involving DNA damage response and repair, chromatic modification and gene regulation, development and differentiation, and cell cycle were identified. p-values are shown at the right of each bar. *NS, not significant. 7

8 SUPPLEMENTARY INFORMATION Supplementary Data 5: Gene expression in individual cells from tissues with low, intermediate, or high metastatic burden. Box plots show expression levels for each differentially expressed gene (p<0.05) in individual cells. P-values and fold change for each gene are shown in Extended Data Table 2. Black dots, single cells; red dots, single cells with no expression. 8

9 Supplementary Data 6: Kaplan-Meier analysis shows the prognostic relevance of 16 genes characteristic of low-burden metastatic cells. The prognostic value of each of the 55 genes characteristic of low-burden metastatic cells (Extended Data Table 2) was determined by Kaplan-Meier analysis using Km-plotter online software. 29 Km plots are shown as probability of distant metastasis-free survival (DMFS). 16 of 55 genes were found to be prognostic: High ACTA2, CHEK1, EPHA4, MYCN, NOTCH3, NOTCH4, SKP2, TGFB1, TGFB2, THY1 and TWIST1 expression was associated with increased risk of distant metastasis, and increased CDH1, ERBB3, MUC1 and PTEN expression was associated with reduced risk of metastasis. 9

10 SUPPLEMENTARY INFORMATION Supplementary Data 7: Gene expression in individual primary tumor cells and metastatic cells from the lung, lymph node, peripheral blood, bone marrow, and brain Supplementary Data 7: Gene expression in individual primary tumor and metastatic cells from the lung, lymph node, peripheral blood, bone marrow, and brain. Box plots show all genes (80) that were significantly differentially expressed (p<0.05, ANOVA) between at least one pair of tissues. The p-value and fold change for each gene and tissue pair and are shown in Supplementary Table 3. Each black dot represents expression in a single cell, and red dots represent non-expressing cells. LU, lung; LN, lymph node; BM, bone marrow; PB, peripheral blood (CTC); BR, brain. 11 Supplementary Data 8: Histogram plots show the distribution of cells yielded following tissue dissociation of lungs and lymph nodes from PDX animals. For consistency, any tissue digests which yielded an abnormal number of cells (>1 standard deviation from the mean) was excluded from the study. This allowed for comparison of the number of metastatic cells in different animals with reasonable consistency. 1 0 W W W. N A T U R E. C O M / N A T U R E

11 Number of animals Lung x = 6.6x10 6-1σ +1σ Number of animals σ Lymph node x = 1.7x σ Total cell number (x10 6 ) Total cell number (x10 6 ) Supplementary Data 8: Histogram plots show the distribution of cells yielded following tissue dissociation of lungs and lymph nodes from PDX animals. For consistency, any tissue digests which yielded an abnormal number of cells (>1 standard deviation from the mean) was excluded from the study. This allowed for comparison of the number of metastatic cells in different animals with reasonable consistency. 11

Supplemental Information. High-Throughput Microfluidic Labyrinth for the. Label-free Isolation of Circulating Tumor Cells

Supplemental Information. High-Throughput Microfluidic Labyrinth for the. Label-free Isolation of Circulating Tumor Cells Cell Systems, Volume 5 Supplemental Information High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells Eric Lin, Lianette Rivera-Báez, Shamileh Fouladdel, Hyeun

More information

Title: Single Cell Dual Adherent-Suspension Co-Culture Micro-Environment for Studying Tumor- Stromal Interactions

Title: Single Cell Dual Adherent-Suspension Co-Culture Micro-Environment for Studying Tumor- Stromal Interactions Electronic Supplementary Material (ESI) for Lab on a Chip. This journal is The Royal Society of Chemistry 2016 Title: Single Cell Dual Adherent-Suspension Co-Culture Micro-Environment for Studying Tumor-

More information

Figure S1. ERBB3 mrna levels are elevated in Luminal A breast cancers harboring ERBB3

Figure S1. ERBB3 mrna levels are elevated in Luminal A breast cancers harboring ERBB3 Supplemental Figure Legends. Figure S1. ERBB3 mrna levels are elevated in Luminal A breast cancers harboring ERBB3 ErbB3 gene copy number gain. Supplemental Figure S1. ERBB3 mrna levels are elevated in

More information

Identifying genomic signatures in circulating breast tumour cells

Identifying genomic signatures in circulating breast tumour cells Identifying genomic signatures in circulating breast tumour cells 9 th ISMRC 2013, Paris, France September 25th, 2013 NISHA KANWAR PhD Candidate Department of Laboratory Medicine and Pathobiology University

More information

Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity

Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity Aleix Prat, Barbara Adamo, Cheng Fan, Vicente Peg, Maria Vidal, Patricia Galván, Ana Vivancos, Paolo

More information

The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis

The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis Tieliu Shi tlshi@bio.ecnu.edu.cn The Center for bioinformatics

More information

The Avatar System TM Yields Biologically Relevant Results

The Avatar System TM Yields Biologically Relevant Results Application Note The Avatar System TM Yields Biologically Relevant Results Liquid biopsies stand to revolutionize the cancer field, enabling early detection and noninvasive monitoring of tumors. In the

More information

TEB. Id4 p63 DAPI Merge. Id4 CK8 DAPI Merge

TEB. Id4 p63 DAPI Merge. Id4 CK8 DAPI Merge a Duct TEB b Id4 p63 DAPI Merge Id4 CK8 DAPI Merge c d e Supplementary Figure 1. Identification of Id4-positive MECs and characterization of the Comma-D model. (a) IHC analysis of ID4 expression in the

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Phenotypic characterization of MES- and ADRN-type cells.

Nature Genetics: doi: /ng Supplementary Figure 1. Phenotypic characterization of MES- and ADRN-type cells. Supplementary Figure 1 Phenotypic characterization of MES- and ADRN-type cells. (a) Bright-field images showing cellular morphology of MES-type (691-MES, 700-MES, 717-MES) and ADRN-type (691-ADRN, 700-

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10134 Supplementary Figure 1. Anti-inflammatory activity of sfc. a, Autoantibody immune complexes crosslink activating Fc receptors, promoting activation of macrophages, and WWW.NATURE.COM/NATURE

More information

Supplementary. properties of. network types. randomly sampled. subsets (75%

Supplementary. properties of. network types. randomly sampled. subsets (75% Supplementary Information Gene co-expression network analysis reveals common system-level prognostic genes across cancer types properties of Supplementary Figure 1 The robustness and overlap of prognostic

More information

SUPPLEMENTARY APPENDIX

SUPPLEMENTARY APPENDIX SUPPLEMENTARY APPENDIX 1) Supplemental Figure 1. Histopathologic Characteristics of the Tumors in the Discovery Cohort 2) Supplemental Figure 2. Incorporation of Normal Epidermal Melanocytic Signature

More information

Supplementary Figure 1. Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Nature Immunology: doi: /ni.

Supplementary Figure 1. Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Nature Immunology: doi: /ni. Supplementary Figure 1 Efficiency of Mll4 deletion and its effect on T cell populations in the periphery. Expression of Mll4 floxed alleles (16-19) in naive CD4 + T cells isolated from lymph nodes and

More information

UC Irvine UC Irvine Previously Published Works

UC Irvine UC Irvine Previously Published Works UC Irvine UC Irvine Previously Published Works Title Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells Permalink https://escholarship.org/uc/item/0x8772xv Journal

More information

Supplementary Figure S1 Expression of mir-181b in EOC (A) Kaplan-Meier

Supplementary Figure S1 Expression of mir-181b in EOC (A) Kaplan-Meier Supplementary Figure S1 Expression of mir-181b in EOC (A) Kaplan-Meier curves for progression-free survival (PFS) and overall survival (OS) in a cohort of patients (N=52) with stage III primary ovarian

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10866 a b 1 2 3 4 5 6 7 Match No Match 1 2 3 4 5 6 7 Turcan et al. Supplementary Fig.1 Concepts mapping H3K27 targets in EF CBX8 targets in EF H3K27 targets in ES SUZ12 targets in ES

More information

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018 Targeted Agent and Profiling Utilization Registry (TAPUR ) Study February 2018 Precision Medicine Therapies designed to target the molecular alteration that aids cancer development 30 TARGET gene alterations

More information

(A) Cells grown in monolayer were fixed and stained for surfactant protein-c (SPC,

(A) Cells grown in monolayer were fixed and stained for surfactant protein-c (SPC, Supplemental Figure Legends Figure S1. Cell line characterization (A) Cells grown in monolayer were fixed and stained for surfactant protein-c (SPC, green) and co-stained with DAPI to visualize the nuclei.

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:.38/nature8975 SUPPLEMENTAL TEXT Unique association of HOTAIR with patient outcome To determine whether the expression of other HOX lincrnas in addition to HOTAIR can predict patient outcome, we measured

More information

Expanded View Figures

Expanded View Figures Molecular Systems iology Tumor CNs reflect metabolic selection Nicholas Graham et al Expanded View Figures Human primary tumors CN CN characterization by unsupervised PC Human Signature Human Signature

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION DOI: 10.1038/ncb2607 Figure S1 Elf5 loss promotes EMT in mammary epithelium while Elf5 overexpression inhibits TGFβ induced EMT. (a, c) Different confocal slices through the Z stack image. (b, d) 3D rendering

More information

TP53 Mutation, Epithelial-Mesenchymal Transition, and Stemlike Features in Breast Cancer Subtypes

TP53 Mutation, Epithelial-Mesenchymal Transition, and Stemlike Features in Breast Cancer Subtypes Journal of Biomedicine and Biotechnology Volume 0, Article ID 0, pages doi:0./0/0 Research Article TP Mutation, Epithelial-Mesenchymal Transition, and Stemlike Features in Breast Cancer Subtypes Danila

More information

Table S1: Analysis of Notch gene rearrangements in triple negative breast cancer subtypes

Table S1: Analysis of Notch gene rearrangements in triple negative breast cancer subtypes Supplemental Tables Table S1: Analysis of Notch gene rearrangements in triple negative breast cancer subtypes NOTCH1 or NOTCH2 Basal Immune Luminal AR Mesenchymal Stem Like WT 27 (87%) 24 (100%) 4 (66%)

More information

Breast cancer classification: beyond the intrinsic molecular subtypes

Breast cancer classification: beyond the intrinsic molecular subtypes Breast cancer classification: beyond the intrinsic molecular subtypes Britta Weigelt, PhD Signal Transduction Laboratory CRUK London Research Institute Summary Breast cancer heterogeneity Molecular classification

More information

Phosphorylation Site Company Cat #

Phosphorylation Site Company Cat # Supplemental Table 1. Antibodies used for RPPA analysis. Label Protein Phosphorylation Site Company Cat # Used on MDA_CLSS Used on MDA_Pilot 4EBP1 4EBP1 Cell Signaling 9452 No 4EBP1.pS65 4EBP1 S65 Cell

More information

Supplementary Figure S1. Gene expression analysis of epidermal marker genes and TP63.

Supplementary Figure S1. Gene expression analysis of epidermal marker genes and TP63. Supplementary Figure Legends Supplementary Figure S1. Gene expression analysis of epidermal marker genes and TP63. A. Screenshot of the UCSC genome browser from normalized RNAPII and RNA-seq ChIP-seq data

More information

Supplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs.

Supplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs. Supplementary Figure 1: Comparison of acgh-based and expression-based CNA analysis of tumors from breast cancer GEMMs. (a) CNA analysis of expression microarray data obtained from 15 tumors in the SV40Tag

More information

Nature Immunology: doi: /ni Supplementary Figure 1. Transcriptional program of the TE and MP CD8 + T cell subsets.

Nature Immunology: doi: /ni Supplementary Figure 1. Transcriptional program of the TE and MP CD8 + T cell subsets. Supplementary Figure 1 Transcriptional program of the TE and MP CD8 + T cell subsets. (a) Comparison of gene expression of TE and MP CD8 + T cell subsets by microarray. Genes that are 1.5-fold upregulated

More information

Prognosis for metastatic breast cancer to bones

Prognosis for metastatic breast cancer to bones Prognosis for metastatic breast cancer to bones The Borg System is 100 % Prognosis for metastatic breast cancer to bones Jul 23, 2013. Purpose. Bone is the most frequent site of metastasis among breast

More information

Molecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue.

Molecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue. Innovation for your breast cancer diagnostics PGR G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C G AT C G A A A G A A G T TA G ATA G C G A C ERBB2

More information

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice Supplementary figure legends Supplementary Figure 1. Characterization of after reconstitution of SCID mice with CD4 + CD62L + T cells. (A-C) SCID mice (n = 6 / group) were reconstituted with 2 x 1 6 CD4

More information

Early dissemination in prostate cancer

Early dissemination in prostate cancer Early dissemination in prostate cancer Miodrag Guzvic, University of Regensburg, Germany Adjuvant Palliative M0 Initiation Diagnosis Surgery Metastasis Death Intervention window to delay or prevent metastasis

More information

Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation

Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation Supplementary Figure 1 ITGB1 and ITGA11 increase with evidence for heterodimers following HSC activation. (a) Time course of rat HSC activation indicated by the detection of -SMA and COL1 (log scale).

More information

Recent advances in breast cancers

Recent advances in breast cancers Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response

More information

Contemporary Classification of Breast Cancer

Contemporary Classification of Breast Cancer Contemporary Classification of Breast Cancer Laura C. Collins, M.D. Vice Chair of Anatomic Pathology Professor of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Outline

More information

Morphological and Molecular Typing of breast Cancer

Morphological and Molecular Typing of breast Cancer Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological

More information

Supplementary Table 1: List of the 242 hypoxia/reoxygenation marker genes collected from literature and databases

Supplementary Table 1: List of the 242 hypoxia/reoxygenation marker genes collected from literature and databases Supplementary Tables: Supplementary Table 1: List of the 242 hypoxia/reoxygenation marker genes collected from literature and databases Supplementary Table 2: Contingency tables used in the fisher exact

More information

Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer

Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer R. Joseph Bender, Feilim Mac Gabhann* Institute for Computational Medicine and Department of Biomedical Engineering,

More information

Patient characteristics of training and validation set. Patient selection and inclusion overview can be found in Supp Data 9. Training set (103)

Patient characteristics of training and validation set. Patient selection and inclusion overview can be found in Supp Data 9. Training set (103) Roepman P, et al. An immune response enriched 72-gene prognostic profile for early stage Non-Small- Supplementary Data 1. Patient characteristics of training and validation set. Patient selection and inclusion

More information

Carcinome du sein Biologie moléculaire. Thomas McKee Service de Pathologie Clinique Genève

Carcinome du sein Biologie moléculaire. Thomas McKee Service de Pathologie Clinique Genève Carcinome du sein Biologie moléculaire Thomas McKee Service de Pathologie Clinique Genève Pathology Diagnostic Prognostic information Predictive information The information provided depends on the available

More information

Gene Signatures in Breast Cancer: Moving Beyond ER, PR, and HER2? Lisa A. Carey, M.D. University of North Carolina USA

Gene Signatures in Breast Cancer: Moving Beyond ER, PR, and HER2? Lisa A. Carey, M.D. University of North Carolina USA Gene Signatures in Breast Cancer: Moving Beyond ER, PR, and HER2? Lisa A. Carey, M.D. University of North Carolina USA When Are Biomarkers Ready To Use? Same Rules for Gene Expression Panels Key elements

More information

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION DOI: 1.138/ncb3355 a S1A8 + cells/ total.1.8.6.4.2 b S1A8/?-Actin c % T-cell proliferation 3 25 2 15 1 5 T cells Supplementary Figure 1 Inter-tumoral heterogeneity of MDSC accumulation in mammary tumor

More information

Proteomic Biomarker Discovery in Breast Cancer

Proteomic Biomarker Discovery in Breast Cancer Proteomic Biomarker Discovery in Breast Cancer Rob Baxter Laboratory for Cellular and Diagnostic Proteomics Kolling Institute, University of Sydney, Royal North Shore Hospital robert.baxter@sydney.edu.au

More information

Impact of Prognostic Factors

Impact of Prognostic Factors Melanoma Prognostic Factors: where we started, where are we going? Impact of Prognostic Factors Staging Management Surgical intervention Adjuvant treatment Suraj Venna, MD Assistant Clinical Professor,

More information

Nature Methods: doi: /nmeth Supplementary Figure 1

Nature Methods: doi: /nmeth Supplementary Figure 1 Supplementary Figure 1 Finite-element analysis of cell cluster dynamics in different cluster trap architectures. (a) Cluster-Chip (b) Filter (c) A structure identical to the Cluster-Chip except that one

More information

HER2-Targeted Rx. An Historical Perspective

HER2-Targeted Rx. An Historical Perspective HER2-Targeted Rx An Historical Perspective Trastuzumab: Front Line Rx for MBC Median 20.3 v. 25.1 mo P = 0.046 HR 0.8 65% of control patients crossed over Slamon D, et al. N Engl J Med, 2001; 344:783 Trastuzumab:Front-line

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature12215 Supplementary Figure 1. The effects of full and dissociated GR agonists in supporting BFU-E self-renewal divisions. BFU-Es were cultured in self-renewal medium with indicated GR

More information

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015 Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a

More information

Sesiones interhospitalarias de cáncer de mama. Revisión bibliográfica 4º trimestre 2015

Sesiones interhospitalarias de cáncer de mama. Revisión bibliográfica 4º trimestre 2015 Sesiones interhospitalarias de cáncer de mama Revisión bibliográfica 4º trimestre 2015 Selected papers Prospective Validation of a 21-Gene Expression Assay in Breast Cancer TAILORx. NEJM 2015 OS for fulvestrant

More information

Molecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue.

Molecular in vitro diagnostic test for the quantitative detection of the mrna expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue. Innovation for your breast cancer diagnostics Now valid ated on: -Roche cob as z 480 A nalyzer -Roche L ightcycle r 480 II - ABI 750 0 Fast -Versant kpcr Cyc ler PGR ESR1 MKI67 Molecular in vitro diagnostic

More information

Genomic Medicine: What every pathologist needs to know

Genomic Medicine: What every pathologist needs to know Genomic Medicine: What every pathologist needs to know Stephen P. Ethier, Ph.D. Professor, Department of Pathology and Laboratory Medicine, MUSC Director, MUSC Center for Genomic Medicine Genomics and

More information

FISH mcgh Karyotyping ISH RT-PCR. Expression arrays RNA. Tissue microarrays Protein arrays MS. Protein IHC

FISH mcgh Karyotyping ISH RT-PCR. Expression arrays RNA. Tissue microarrays Protein arrays MS. Protein IHC Classification of Breast Cancer in the Molecular Era Susan J. Done University Health Network, Toronto Why classify? Prognosis Prediction of response to therapy Pathogenesis Invasive breast cancer can have

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature13173 Supplementary Table 1. List of genes commonly expressed in all single cells. Name Actb Actin, beta, cytoplasmic Actg1 Actin, gamma, cytoplasmic 1 Atp5e ATP synthase, H+ transporting,

More information

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors

More information

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Assessment and Management of Genetic Predisposition to Breast Cancer Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Overview The role of the Cancer Genetics team NICE guidelines for Familial Breast

More information

Molecular Enhancement of Sentinel Node Evaluation

Molecular Enhancement of Sentinel Node Evaluation Cochran Illustrations 060104 Molecular Enhancement of Sentinel Node Evaluation Alistair Cochran, MD and Rong Huang MD Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of

More information

Nature Immunology: doi: /ni Supplementary Figure 1. Huwe1 has high expression in HSCs and is necessary for quiescence.

Nature Immunology: doi: /ni Supplementary Figure 1. Huwe1 has high expression in HSCs and is necessary for quiescence. Supplementary Figure 1 Huwe1 has high expression in HSCs and is necessary for quiescence. (a) Heat map visualizing expression of genes with a known function in ubiquitin-mediated proteolysis (KEGG: Ubiquitin

More information

Comparison of prognostic signatures for ER positive breast cancer in TransATAC:

Comparison of prognostic signatures for ER positive breast cancer in TransATAC: Comparison of prognostic signatures for ER positive breast cancer in TransATAC: EndoPredict, a high performance test in node negative and node positive disease Ivana Sestak, PhD Centre for Cancer Prevention

More information

Supplementary Information

Supplementary Information Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting

More information

stomach p63/krt5 CDH17 CEACAM5 CEACAM7 ANXA13 ANXA10 CLDN18 VSIG1 TFF2 VIL1 GDA

stomach p63/krt5 CDH17 CEACAM5 CEACAM7 ANXA13 ANXA10 CLDN18 VSIG1 TFF2 VIL1 GDA Supplementary Fig. 1 a esophagus Barrett s e FABP1 Ecad stomach TFF3 b p63/krt5 CDH17 REG4 CDH17 f c signal intensity p63/krt5 EsoSC 5000 4000 3000 2000 CDH17 1500 1000 Barrett s KRT14 KRT6A KRT13 KRT5

More information

Table S2. Expression of PRMT7 in clinical breast carcinoma samples

Table S2. Expression of PRMT7 in clinical breast carcinoma samples Table S2. Expression of PRMT7 in clinical breast carcinoma samples (All data were obtained from cancer microarray database Oncomine.) Analysis type* Analysis Class(number sampels) 1 2 3 4 Correlation (up/down)#

More information

Molecular classification of breast cancer implications for pathologists. Sarah E Pinder

Molecular classification of breast cancer implications for pathologists. Sarah E Pinder Molecular classification of breast cancer implications for pathologists Sarah E Pinder Courtesy of CW Elston Histological types Breast Cancer Special Types 17 morphological special types 25-30% of all

More information

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Research article Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Brian D. Lehmann, 1 Joshua A. Bauer, 1 Xi Chen, 2 Melinda E. Sanders,

More information

Cancer cells in vitro

Cancer cells in vitro Supplementary Figure S1 Cancer cells in vitro Pretreatment with Control IgG (18h) Pretreatment with anti-u-par (18h) Acid Wash/Pretreatment with Control IgG (18h) Acid Wash/Pretreatment with anti-u-par

More information

Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival -- Evidence from TCGA Pan-Cancer Data

Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival -- Evidence from TCGA Pan-Cancer Data Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival -- Evidence from TCGA Pan-Cancer Data Supplementary Materials Xiu Huang, David Stern, and

More information

Identifying transcriptional dichotomies by "stochastic sampling"

Identifying transcriptional dichotomies by stochastic sampling Identifying transcriptional dichotomies by "stochastic sampling" Kevin Janes and Joan Brugge Department of Cell Biology Harvard Medical School pakt (S473) keratin 10 DAPI National Cancer Institute (CA105134)

More information

Models of cell signalling uncover molecular mechanisms of high-risk neuroblastoma and predict outcome

Models of cell signalling uncover molecular mechanisms of high-risk neuroblastoma and predict outcome Models of cell signalling uncover molecular mechanisms of high-risk neuroblastoma and predict outcome Marta R. Hidalgo 1, Alicia Amadoz 2, Cankut Çubuk 1, José Carbonell-Caballero 2 and Joaquín Dopazo

More information

Journal: Nature Methods

Journal: Nature Methods Journal: Nature Methods Article Title: Network-based stratification of tumor mutations Corresponding Author: Trey Ideker Supplementary Item Supplementary Figure 1 Supplementary Figure 2 Supplementary Figure

More information

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value Lehmann et al. BMC Cancer (2015) 15:179 DOI 10.1186/s12885-015-1102-7 RESEARCH ARTICLE Open Access Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic

More information

Breast Cancer: ASCO Poster Review

Breast Cancer: ASCO Poster Review Breast Cancer: ASCO Poster Review Carmen Criscitiello, MD, PhD Istituto Europeo di Oncologia Milano HER2+ SUBTYPE Research questions in early HER2+ BC De-escalation of toxicity without compromising efficacy

More information

Modern classification of breast cancer-should we stick with morphology or convert to molecular profiles?

Modern classification of breast cancer-should we stick with morphology or convert to molecular profiles? Modern classification of breast cancer-should we stick with morphology or convert to molecular profiles? Ian Ellis Professor of Cancer Pathology Molecular Medical Sciences University of Nottingham Dept

More information

Supplementary Tables. Supplementary Figures

Supplementary Tables. Supplementary Figures Supplementary Files for Zehir, Benayed et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients Supplementary Tables Supplementary Table 1: Sample

More information

Plasma-Seq conducted with blood from male individuals without cancer.

Plasma-Seq conducted with blood from male individuals without cancer. Supplementary Figures Supplementary Figure 1 Plasma-Seq conducted with blood from male individuals without cancer. Copy number patterns established from plasma samples of male individuals without cancer

More information

Comparative study of multicellular tumor spheroid formation methods and implications for drug screening

Comparative study of multicellular tumor spheroid formation methods and implications for drug screening Supporting Information Comparative study of multicellular tumor spheroid formation methods and implications for drug screening Maria F. Gencoglu, Lauren E. Barney, Christopher L. Hall, Elizabeth A. Brooks,

More information

SureSelect Cancer All-In-One Custom and Catalog NGS Assays

SureSelect Cancer All-In-One Custom and Catalog NGS Assays SureSelect Cancer All-In-One Custom and Catalog NGS Assays Detect all cancer-relevant variants in a single SureSelect assay SNV Indel TL SNV Indel TL Single DNA input Single AIO assay Single data analysis

More information

The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer

The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer Welcome! The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer Prof. Sabine Kasimir-Bauer Department of Gynecology and Obstetrics University Hospital

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/7/283/283ra54/dc1 Supplementary Materials for Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

More information

Should we still be performing IHC on all sentinel nodes?

Should we still be performing IHC on all sentinel nodes? Miami Breast Cancer Conference 31 st Annual Conference March 8, 2014 Should we still be performing IHC on all sentinel nodes? Donald L. Weaver, MD Professor of Pathology University of Vermont USA Miami

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Supplementary Fig. 1. Galectin-3 is present within tumors. (A) mrna expression levels of Lgals3 (galectin-3) and Lgals8 (galectin-8) in the four classes of cell lines as determined

More information

Supplementary Figure 1: Experimental design. DISCOVERY PHASE VALIDATION PHASE (N = 88) (N = 20) Healthy = 20. Healthy = 6. Endometriosis = 33

Supplementary Figure 1: Experimental design. DISCOVERY PHASE VALIDATION PHASE (N = 88) (N = 20) Healthy = 20. Healthy = 6. Endometriosis = 33 DISCOVERY PHASE (N = 20) Healthy = 6 Endometriosis = 7 EAOC = 7 Quantitative PCR (mirnas = 1113) a Quantitative PCR Verification of Candidate mirnas (N = 24) VALIDATION PHASE (N = 88) Healthy = 20 Endometriosis

More information

Expanded View Figures

Expanded View Figures EMO Molecular Medicine Proteomic map of squamous cell carcinomas Hanibal ohnenberger et al Expanded View Figures Figure EV1. Technical reproducibility. Pearson s correlation analysis of normalised SILC

More information

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment? Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen

More information

Relationship between genomic features and distributions of RS1 and RS3 rearrangements in breast cancer genomes.

Relationship between genomic features and distributions of RS1 and RS3 rearrangements in breast cancer genomes. Supplementary Figure 1 Relationship between genomic features and distributions of RS1 and RS3 rearrangements in breast cancer genomes. (a,b) Values of coefficients associated with genomic features, separately

More information

and follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the

and follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the Supplementary Figure 1. LAG3 + Treg-mediated regulation of germinal center B cells and follicular helper T cells is Egr2-dependent. (a) Diagrammatic representation of the experimental protocol for the

More information

AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?

AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? FCRA Annual Conference Boca Raton, Florida 7/26/2016 Steven Peace, CTR 1 Introduction Order AJCC Cancer Staging Manual, 7 th ed. How To Use - AJCC Cancer

More information

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq ARTICLE DOI:.8/s67-8-6- OPEN Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq 6789():,; Mihriban Karaayvaz, Simona Cristea,,, Shawn M. Gillespie,, Anoop

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10188 Supplementary Figure 1. Embryonic epicardial genes are down-regulated from midgestation stages and barely detectable post-natally. Real time qrt-pcr revealed a significant down-regulation

More information

Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester

Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester Dr David Guttery Senior PDRA Dept. of Cancer Studies and CRUK Leicester Centre University of Leicester dsg6@le.ac.uk CFDNA/CTDNA Circulating-free AS A LIQUID DNA BIOPSY (cfdna) Tumour Biopsy Liquid Biopsy

More information

* * * * Supplementary Figure 1. DS Lv CK HSA CK HSA. CK Col-3. CK Col-3. See overleaf for figure legend. Cancer cells

* * * * Supplementary Figure 1. DS Lv CK HSA CK HSA. CK Col-3. CK Col-3. See overleaf for figure legend. Cancer cells Supplementary Figure 1 Cancer cells Desmoplastic stroma Hepatocytes Pre-existing sinusoidal blood vessel New blood vessel a Normal liver b Desmoplastic HGP c Pushing HGP d Replacement HGP e f g h i DS

More information

The Center for PERSONALIZED DIAGNOSTICS

The Center for PERSONALIZED DIAGNOSTICS The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)

More information

Basement membrane in lobule.

Basement membrane in lobule. Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.

More information

Nature Medicine: doi: /nm.3967

Nature Medicine: doi: /nm.3967 Supplementary Figure 1. Network clustering. (a) Clustering performance as a function of inflation factor. The grey curve shows the median weighted Silhouette widths for varying inflation factors (f [1.6,

More information

SCATTER PLOTS AND TREND LINES

SCATTER PLOTS AND TREND LINES 1 SCATTER PLOTS AND TREND LINES LEARNING MAP INFORMATION STANDARDS 8.SP.1 Construct and interpret scatter s for measurement to investigate patterns of between two quantities. Describe patterns such as

More information

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins. WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE

More information

PROSTATE CANCER HORMONE THERAPY AND BEYOND. Przemyslaw Twardowski MD Professor of Oncology Department of Urologic Oncology John Wayne Cancer Institute

PROSTATE CANCER HORMONE THERAPY AND BEYOND. Przemyslaw Twardowski MD Professor of Oncology Department of Urologic Oncology John Wayne Cancer Institute PROSTATE CANCER HORMONE THERAPY AND BEYOND Przemyslaw Twardowski MD Professor of Oncology Department of Urologic Oncology John Wayne Cancer Institute Disclosures I am a Consultant for Bayer and Sanofi-Aventis

More information

ENFERMEDAD AVANZADA Qué hacemos con el triple negativo? Nuevas aproximaciones

ENFERMEDAD AVANZADA Qué hacemos con el triple negativo? Nuevas aproximaciones ENFERMEDAD AVANZADA Qué hacemos con el triple negativo? Nuevas aproximaciones Javier Cortes, Hospital Universitario Ramon y Cajal, Madrid Vall d Hebron Institute of Oncology (VHIO), Barcelona Triple Negative

More information

Research Article Breast Cancer Prognosis Risk Estimation Using Integrated Gene Expression and Clinical Data

Research Article Breast Cancer Prognosis Risk Estimation Using Integrated Gene Expression and Clinical Data BioMed Research International, Article ID 459203, 15 pages http://dx.doi.org/10.1155/2014/459203 Research Article Breast Cancer Prognosis Risk Estimation Using Integrated Gene Expression and Clinical Data

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Frampton et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing Supplementary Figure 1A Base substitution detection

More information